Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus

Pei-Feng Liu, Yanhan Wang, Yu-Tsueng Liu, Chun-Ming Huang

Department of Dermatology, University of California, San Diego, San Diego, USA. Division of Infectious Diseases, Department of Medicine, University of California, San Diego, USA. Moores Cancer Center, University of California, San Diego, San Diego, USA


Cover Image

There is a need for a fast and simple method for vaccine production to keep up with the pace of a rapidly spreading virus in the early phases of the influenza pandemic. The use of whole viruses produced in chicken eggs or recombinant antigens purified from various expression systems has presented considerable challenges, especially with lengthy processing times. Here, we use the killed but metabolically active (KBMA) Escherichia coli (E. coli) to harbor the hemagglutinin (HA) of swine origin influenza A (H1N1) virus (S-OIV) San Diego/01/09 (SD/H1N1-S-OIV). Intranasal vaccination of mice with KBMA E. coli SD/H1N1-S-OIV HA without adding exogenous adjuvants provoked detectable neutralizing antibodies against the virus-induced hemagglutination within three weeks. Boosting vaccination enhanced the titers of neutralizing antibodies, which can decrease viral infectivity in Madin-Darby canine kidney (MDCK) cells. The antibodies were found to specifically neutralize the SD/H1N1-S-OIV-, but not seasonal influenza viruses (H1N1 and H3N2), -induced hemagglutination. The use of KBMA E. coli as an egg-free system to produce anti-influenza vaccines makes unnecessary the rigorous purification of an antigen prior to immunization, providing an alternative modality to combat influenza virus in future outbreaks. Journal of Nature and Science (JNSCI), 3(2):e317, 2017



HomeAbout JNSCI Privacy PolicyPeer ReviewPub Fee
Author Guidance 

©2017 Journal of Nature and Science (JNSCI), Los Angeles, CA: JNSCI.org | ISSN 2377-2700 | Contact: editor@jnsci.org